Published in Gene Therapy Weekly, February 10th, 2000
At the 7th Meeting of the European Society of Gene Therapy, held November 26-28, 1999, in Munich, Germany, Mi-Ae Kang and colleagues presented their study in which they blocked VEGF to induce tumor regression. Their study is titled "The growth inhibition of hepatoma cells by gene transfer of antisense vascular endothelial growth factor."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.